Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 25, 2024 08:05 ET | Source: Tevogen Bio Inc

Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances

WARREN, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...
January 23, 2019 09:00 ET | Source: Elsalys Biotech

L’analyse de survie à long terme de l’étude de phase III randomisée démontre un bénéfice clinique évident de l’inolimomab dans le traitement de la SR-aGvHD

L’analyse de survie à long terme de l’étude de phase III randomisée démontre un bénéfice clinique évident de l’inolimomab dans le traitement de la SR-aGvHD Le suivi des patients de l’étude de phase...
January 23, 2019 09:00 ET | Source: Elsalys Biotech

Long-term survival analysis of the randomised Phase III study shows a clear clinical benefit of inolimomab in SR-aGvHD

Long-term survival analysis of the randomised Phase III study shows a clear clinical benefit of inolimomab in SR-aGvHD Follow-up of INO-107 Phase III study patients up to 8.5 years is the first...